HDQ-P1Homo sapiens (Human)Cancer cell line

Also known as: HDQP1

🤖 AI SummaryBased on 6 publications

Quick Overview

Human breast cancer cell line with unique molecular characteristics.

Detailed Summary

The HDQ-P1 cell line was established from a primary ductal infiltrating mammary carcinoma and has been cultured for over 115 passages. It exhibits an epithelial morphology with features such as polygonal cells, large nuclei, and abnormal mitotic figures. The cell line shows a polyploid karyotype with 20 recurrent marker chromosomes. HDQ-P1 is negative for estrogen and progesterone receptors and expresses human telomerase reverse transcriptase (hTERT) similar to other breast cancer cell lines. It has a five-fold amplification of the C-MYC gene but no amplification of C-ERBB-2 or C-H-RAS. The cell line is capable of anchorage-independent growth and shows tumorigenic potential in nude mice, although tumor formation was not observed in all experiments. HDQ-P1 is used in research for studying breast cancer biology, drug sensitivity, and molecular mechanisms of tumorigenesis.

Research Applications

Breast cancer biologyDrug sensitivity testingMolecular mechanisms of tumorigenesisGenomic and proteomic profiling

Key Characteristics

Epithelial morphologyPolyploid karyotypeNegative for estrogen and progesterone receptorsAmplified C-MYCTumorigenic in nude miceAnchorage-independent growth
Generated on 6/18/2025

Basic Information

Database IDCVCL_2067
SpeciesHomo sapiens (Human)
Tissue SourceBreast[UBERON:UBERON_0000310]

Donor Information

Age50
Age CategoryAdult
SexFemale
Racecaucasian
Subtype Featuresbasal_A TNBC

Disease Information

DiseaseBreast ductal carcinoma
LineageBreast
SubtypeBreast Invasive Ductal Carcinoma
OncoTree CodeIDC

DepMap Information

Source TypeDSMZ
Source IDACH-000643_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg213Ter (c.637C>T)Unspecified-Unknown
MutationSimpleTMPRSS2p.Gly8Val (c.23G>T) (c.-57+99G>T)Heterozygous-PubMed=34339474
MutationSimpleKDM6Ap.Arg165Ter (c.493C>T)Homozygous-Unknown, Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11
D10S1248
13,14
D12S391
19,21
D13S317
12
D16S539
11
D18S51
13
D19S433
13
D1S1656
13,16.3
D21S11
29
D22S1045
11
D2S1338
17
D2S441
10
D3S1358
15
D5S818
11
D7S820
11,12
D8S1179
12,15
FGA
22
Penta D
11
Penta E
11,13
TH01
9.3
TPOX
8
vWA
16,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies.

Safranko Z.M., Kurolt I.-C., Markotic A., Cicin-Sain L., Steenpass L.

PLoS ONE 16:E0255622-E0255622(2021).

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

Modeling precision treatment of breast cancer.";

Collisson E.A., van 't Veer L.J., Spellman P.T., Gray J.W.

Genome Biol. 14:R110.1-R110.14(2013).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Establishment and characterization of a new cell line derived from a human primary breast carcinoma.

Germain L., Tetu B.

Cancer Genet. Cytogenet. 120:58-72(2000).

Web Resources